AFFX Share Price

Open 14.02 Change Price %
High 14.05 1 Day 0.02 0.14
Low 14.00 1 Week 0.00 0.00
Close 14.01 1 Month 0.00 0.00
Volume 5018346 1 Year 0.16 1.16
52 Week High 16.15
52 Week Low 13.81
AFFX Important Levels
Resistance 2 14.06
Resistance 1 14.04
Pivot 14.02
Support 1 13.98
Support 2 13.96
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
DRYS 1.01 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
NASDAQ USA Top Gainers Stocks
CPSL 0.10 66.67%
LOCM 0.09 50.00%
GLBS 9.70 31.79%
LTRE 2.85 29.55%
ETRM 7.96 29.22%
INFI 2.00 29.03%
QKLS 0.14 27.27%
PRKR 2.57 26.60%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
NASDAQ USA Top Losers Stocks
HEAT 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%

Affymetrix, Inc. (NASDAQ: AFFX)

AFFX Technical Analysis 2
As on 31st Mar 2016 AFFX Share Price closed @ 14.01 and we RECOMMEND Buy for LONG-TERM with Stoploss of 11.16 & Strong Sell for SHORT-TERM with Stoploss of 14.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
AFFX Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
AFFX Other Details
Segment EQ
Market Capital 235848976.00
Sector Technology
Industry Scientific & Technical Instruments
Offical website
AFFX Address
3420 Central Expressway
Santa Clara, CA 95051
United States
Phone: 408-731-5000
Fax: 408-731-5380
AFFX Latest News
Will The Needle Move For Affymetrix, Inc. (NASDAQ:AFFX) Shares This Earnings ...   Wall Street Beacon   - 19th Jan 17
Affymetrix, Inc. (NASDAQ:AFFX) Under Analyst Spotlight   UK Market News   - 18th Jan 17
Affymetrix, Inc. (NASDAQ:AFFX) 50-day MA At $14.15   Equities Focus   - 15th Jan 17
Affymetrix, Inc. (NASDAQ:AFFX) Short-Term Price Target At $13.92   Equities Focus   - 28th Oct 16
Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against ...   PR Newswire (press release)   - 30th Mar 16
Origin Technologies Drops Affymetrix Offer After Being Rejected   Bloomberg   - 29th Mar 16
Affymetrix to Engage in Discussions With Origin Technologies   Business Wire (press release)   - 24th Mar 16
Affymetrix Inc. (AFFX) Jumps 14.05% on March 18   - 19th Mar 16
Former Affymetrix Senior Executives Propose to Acquire Affymetrix for $16.10 ...   Business Wire (press release)   - 18th Mar 16
Enzo Biochem Reaches $10 Million Patent Infringement Settlement with ...   Business Wire (press release)   - 13th Oct 15
Interactive Technical Analysis Chart Affymetrix, Inc. ( AFFX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Affymetrix, Inc.
AFFX Business Profile
Affymetrix, Inc. (Affymetrix), incorporated in March 1992, is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. Affymetrix has developed its GeneChip system and related microarray technology as a platform for acquiring, analyzing and managing genetic information. The Company offers a line of products for two principal applications: genotyping and gene expression. Related microarray technology also offered by Affymetrix includes licenses for fabricating, scanning, collecting and analyzing results from complementary technologies. The Company sells its products directly to pharmaceutical, biotechnology, agrichemical, diagnostics and consumer products companies, as well as academic research centers, government research laboratories, private foundation laboratories and clinical reference laboratories in North America and Europe. The Company also sells some of its products through life science supply specialists acting as authorized distributors in Latin America, India, the Middle East and Asia Pacific regions, including China. In June 2012, the Company acquired eBioscience Holding Company, Inc., a company with in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. In October 2013, StoneCalibre announced that the completion of the acquisition of Anatrace, a part of Affymetrix, Inc. The Company’s integrated GeneChip microarray platform includes: disposable deoxyribonucleic acid (DNA) probe arrays (chips) consists of nucleic acid sequences and other instruments used to process the probe arrays, and software to analyze and manage genomic or genetic information obtained from the probe arrays. The Company’s technologies include array technology and branched DNA (bDNA) technology. The Company’s array technology leverages semiconductor-based photolithographic fabrication techniques, which enables it to synthesize a variety of predetermined DNA sequences simultaneously in predetermined locations on a small glass chip called an array.